866-997-4948(US-Canada Toll Free)

Haemonetics Corporation (HAE) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 32 Pages


Haemonetics Corporation ( Haemonetics) is engaged in developing, manufacturing and marketing automated blood processing systems. The company manufactures systems and disposables consumed during blood donation, blood typing and screening, and surgical salvage of blood. It operates through a single reportable business segment, which is automated blood typing and screening systems. This segment is classified into four product categories, namely, plasma products and solutions; blood bank products and solutions; hospital products and solutions; and software solutions. Haemonetics renders its services to blood and plasma collectors, hospitals and hospital service providers. The company principally operates in the US, Europe, and Asia, and is headquartered in Massachusetts, the US.

The company aims to expand across geographical regions and expand its product portfolio in order to offer more comprehensive blood management solutions. Haemonetics seeks both organic and inorganic growth strategies in order to meet its objective. Inline with its objective the company recently entered into an agreement to acquire the assets of Hemerus Medical, LLC.

This report is a source for data, analysis and actionable intelligence on the Haemonetics Corporation portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 3

Haemonetics Corporation - Business Description 4

Key Facts 5
Haemonetics Corporation - Major Products and Services 6
Haemonetics Corporation Pipeline Products by Equipment Type 8
Haemonetics Corporation Pipeline Products by Development Stage 10
Automated Whole Blood Collection System 12
Automated Whole Blood Collection System Product Status 12
Automated Whole Blood Collection System Product Description 12
Automated Whole Blood Collection System Product Patent Details 12
Blood Typing System 15
Blood Typing System Product Status 15
Blood Typing System Product Description 15
OrthoPAT Advance 16
OrthoPAT Advance Product Status 16
OrthoPAT Advance Product Description 16
Haemonetics Corporation - Key Competitors 17
Haemonetics Corporation - Key Employees 18
Haemonetics Corporation - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 22
Haemonetics Corporation, Recent Developments 22
Oct 29, 2012: Haemonetics Reports Revenue Of $218.2m In Q2 Fiscal 2013 22
Oct 04, 2012: Haemonetics Showcases Entire Product Portfolio At AABB Meeting In Boston 23
Aug 01, 2012: Haemonetics Reports Revenue Of $176.5m In Q1 Fiscal 2013 24
May 08, 2012: Haemonetics Releases Next Generation Of IMPACT Online Blood Utilization Portal 26
Apr 29, 2012: Haemonetics Reports Revenue Of $727.8m In Fiscal 2012 27
Feb 24, 2012: Haemonetics Names David Helsel As Vice President, Global Manufacturing 28
Jan 30, 2012: Haemonetics Reports Revenue Of $191.2m In Q3 Fiscal 2012 29
Oct 31, 2011: Haemonetics Reports Revenues Of $179.4m In Q2 Fiscal 2012 31
Sep 15, 2011: Court Rules In Favor Of Fenwal In US Patent Dispute With Haemonetics 31
Aug 29, 2011: Haemonetics Appoints Gerry Gould As Vice President, Investor Relations 31

Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Table


Haemonetics Corporation, Key Facts 1
Haemonetics Corporation Key Pipeline Products by Equipment Type 1
Haemonetics Corporation Key Pipeline Products by Development Stage 1
Haemonetics Corporation, Key Facts 5
Haemonetics Corporation, Major Products and Services 6
Haemonetics Corporation Number of Pipeline Products by Equipment Type 8
Haemonetics Corporation Pipeline Products by Equipment Type 9
Haemonetics Corporation Number of Pipeline Products by Development Stage 10
Haemonetics Corporation Pipeline Products by Development Stage 11
Automated Whole Blood Collection System - Product Status 12
Automated Whole Blood Collection System - Product Description 12
Automated Whole Blood Collection System - Patent Details1 12
Automated Whole Blood Collection System - Patent Details2 13
Automated Whole Blood Collection System - Patent Details3 14
Blood Typing System - Product Status 15
Blood Typing System - Product Description 15
OrthoPAT Advance - Product Status 16
OrthoPAT Advance - Product Description 16
Haemonetics Corporation, Key Employees 18
Haemonetics Corporation, Other Locations 19
Haemonetics Corporation, Subsidiaries 20

List of Chart


Haemonetics Corporation Pipeline Products by Equipment Type 8
Haemonetics Corporation Pipeline Products by Development Stage 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *